European Society of Cardiology
Skip navigation links
Home
About the ESC
Membership
Communities
Congresses
Education
Guidelines & Surveys
Journals
Initiatives
Welcome to the European Society of Cardiology. Our mission: to reduce the burden of cardiovascular disease in Europe
 

Device Therapy in Heart Failure (Focused Update)

An update of the 2008 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure and the 2007 ESC guidelines for cardiac and resynchronization therapy

Topics: Heart Failure (HF)

Summary

The current heart failure (HF) guidelines were published in 2008 and the cardiac pacing guidelines in 2007.In order to keep these guidelines up to date, it would be appropriate to modify the recommendations and levels of evidence according to the most recent clinical trial evidence.
This Focused Update on the use of devices in heart failure 2010 is the first publication of its kind from the CPG.
In contrast to previous guidelines, this focused update considers the characteristics of the patients included in the trials and contains several examples.

09/03/2010 00:00:00

Current versions available to download

Publication dateVersionsReferencesSize
2010Full TextEuropean Heart Journal 31:2677–2687351 KB
 Pocket guidelinesPocket Guidelines CRT-HF

Current translated versions available to download:

Authors

Kenneth Dickstein (Chairperson), Panos E. Vardas (Chairperson), Angelo Auricchio,Jean-Claude Daubert, Cecilia Linde, John McMurray, Piotr Ponikowski, Silvia Giuliana Priori, Richard Sutton, Dirk J. van Veldhuisen

Endorsed by:

Table of contents: Focused Update (ESC Clinical Practice Guidelines)

  • Introduction
  • Cardiac resynchronisation therapy with pacemaker/defibrillator function in patients with heart failure in NYHA function class III/IV
  • Cardiac resynchronisaiton therapy with defibrillator function in patients with heart failure in NYHA funciton class I/III
  • Cardiac resynchronisation ttherapy with pacemaker/defibrillator function in patients with heart failure and permanent atrial fibrillation
  • Cardiac resynchronisation therapy with pacemaker/defibrillator function in patients with heart failure ad a conventional pacemaker indication
  • Left ventricular assist device as destination therapy for patients with severe heart failure ineligible for cardiac transplantation
  • Evidence tables
  • References